ACTB gene mutation in combined Dystonia-Deafness syndrome with parkinsonism: Expanding the phenotype and highlighting the long-term GPi DBS outcome

Parkinsonism Relat Disord. 2022 Nov:104:3-6. doi: 10.1016/j.parkreldis.2022.09.012. Epub 2022 Sep 24.

Abstract

We report a Dystonia-Deafness syndrome patient treated by pallidal Deep Brain Stimulation with significant long-term benefits. Our study expands and confirms the complex phenotypic spectrum of ACTB gene-related disorders and supports the effectiveness of pallidal stimulation on motor outcomes and quality of life in dystonia due to ACTB p.Arg183Trp heterozygosity.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins*
  • Deaf-Blind Disorders* / genetics
  • Deaf-Blind Disorders* / therapy
  • Deep Brain Stimulation*
  • Dystonia* / genetics
  • Dystonia* / therapy
  • Female
  • Globus Pallidus / physiology
  • Humans
  • Intellectual Disability* / genetics
  • Intellectual Disability* / therapy
  • Mutation
  • Optic Atrophy* / genetics
  • Optic Atrophy* / therapy
  • Parkinsonian Disorders* / genetics
  • Parkinsonian Disorders* / therapy
  • Phenotype
  • Quality of Life
  • Treatment Outcome

Substances

  • Actins

Supplementary concepts

  • Mohr-Tranebjaerg syndrome